Business Via targets 25%+ revenue growth and first profitable quarter in Q4 2026 amid AI-driven product expansion
Business Fulgent Genetics forecasts $350M 2026 revenue and 53% AP growth as Bako, StrataDx acquisitions reshape customer mix
Business ALX Oncology outlines pivotal trial readiness by end of 2026 with expanded ASPEN-09 study and $150M financing
Business RLJ Lodging Trust targets 0.5%–3% RevPAR growth for 2026 amid urban market momentum and capital allocation flexibility
Business Hawaiian Electric signals $550M–$700M capex for 2026 as wildfire settlements near final approval
Business Calumet targets MaxSAF 150 expansion and $1–$2/gallon SAF contract premiums as operational gains drive leverage reduction
Business DiamondRock targets 1–3% RevPAR growth and $1.09–$1.16 FFO per share in 2026 as it plans capital recycling and disciplined CapEx
Business Energy Fuels outlines uranium production guidance of up to 2.5M pounds in 2026 while expanding rare earth capabilities